The implementation of new systems requires extensive planning and continual oversight. For this reason, the system implementation process is a collaborative effort between IDM and the customer. It is the combined effort of both parties that ensures a successful implementation.

With voluntary independent auditing and a dedicated Regulatory Affairs Department, IDM has focused significant resources on compliance issues from its beginning. IDM was the first company to receive a Traditional 510(k) clearance for blood bank software from the U.S. Food and Drug Administration (FDA) in 1995. IDM was also the first to receive a Special 510(k) clearance under the "New FDA Paradigm". A total of eleven submissions have been cleared with an outstanding record for product turn around time.

IDM provides consulting services for custom software development, validation and regulatory projects on either a fixed fee or time and expense basis.

IDM is fully committed to protecting our customers investments by anticipating industry demands and rapidly responding with the best technology available.